1.Fibrovascular polyp of the esophagus in infant.
Hyo Chae PAIK ; Jae Wook HAN ; Eun Kyu JUNG ; Ki Man BAE ; Young Hyuk LEE
Yonsei Medical Journal 2001;42(2):264-266
A five month female was referred complaining of intermittent vomiting with protrusion of a sausage-like mass through the oral cavity. Esophageal endoscopy and esophagogram revealed a mass in the upper esophagus, which was diagnosed as a fibrovascular polyp. Under general anesthesia, the mass was grasped through the oral cavity with a forcep and ligated and excised at the base, where a stump arose from the posterior wall of the cervical esophagus. The pathology was confirmed as a fibrovascular polyp, which is a rare benign esophageal lesion occurring mostly in adult males, and has not been reported in infancy.
Blood Vessels/pathology
;
Case Report
;
Esophageal Neoplasms/surgery
;
Esophageal Neoplasms/pathology*
;
Esophageal Neoplasms/blood supply
;
Esophagoscopy
;
Female
;
Fibrosis
;
Human
;
Infant
;
Polyps/surgery
;
Polyps/pathology*
;
Polyps/blood supply
2.Research status quo of perfusion imaging with multidetector row computed tomography on esophageal cancer.
Tianwu CHEN ; Zhihui DONG ; Zhigang YANG
Journal of Biomedical Engineering 2011;28(1):179-183
Esophageal cancer is one of frequent malignant tumors worldwide. As a noninvasive technique, computed tomography (CT) perfusion imaging could be valuable to assess the microcirculation of esophageal cancer in vivo. Recently, multidetector row CT (MDCT) perfusion imaging has sparked new interest in the assessment of the microcirculation of esophageal cancer, and therapeutic effects of chemoradiotherapy on this tumor. In this paper, we reviewed the status quo of perfusion imaging with MDCT on esophageal cancer.
Esophageal Neoplasms
;
blood supply
;
diagnostic imaging
;
Humans
;
Models, Theoretical
;
Multidetector Computed Tomography
;
methods
;
Perfusion Imaging
;
methods
;
Regional Blood Flow
3.Oncosis in human esophageal squamous cell carcinoma and its relationship with apoptosis and microvessel density.
Gao-feng ZHAO ; Jing-jing SENG ; Song ZHAO ; Wei HU ; Ang LI ; Xiang-nan LI ; Yu QI
Chinese Medical Journal 2007;120(22):1999-2001
BACKGROUNDPrevious studies have shown that oncosis in malignant tumors might be related to cellular energy supply. The aim of this study was to detect oncosis in human esophageal squamous cell carcinoma (ESCC), and to investigate its relationship with apoptosis and microvessel density (MVD).
METHODSESCC specimens were obtained from 30 patients with ESCC after surgery. Transmission electron microscopy, TUNEL, and immunohistochemistry were used to detect oncosis, apoptosis, and MVD. The relation of oncosis to apoptosis and MVD was analyzed by ANOVA, t test, and q test using SPSS 10.0.
RESULTSTransmission electron microscopy revealed both oncosis and apoptosis in the ECSS tissues. About 10% of the TUNEL-positive cells, which were considered apoptotic cells, showed the characteristics of oncosis. In the areas, where oncotic cells accumulated, apoptotic cells were rare; contrarily, where apoptotic cells gathered, oncotic cells were sparse. Compared with the tissues with a high MVD, the number of oncotic cells was increased and that of apoptotic cells was decreased in the tissues with a low MVD.
CONCLUSIONSCellular oncosis can be detected in human ESCC tissues. The distribution of oncotic cells presents a close relationship with cellular apoptosis and MVD. Oncosis might be induced by poor blood supply.
Aged ; Apoptosis ; Carcinoma, Squamous Cell ; blood supply ; pathology ; Cell Death ; Esophageal Neoplasms ; blood supply ; pathology ; Female ; Humans ; In Situ Nick-End Labeling ; Male ; Middle Aged
4.Notch1 expression in esophageal squamous cell carcinoma and its relation with microvascular angiogenesis.
Chun-Hua SU ; Yu-Long HE ; Zhen-Guang CHEN ; Yi-Yan LEI ; Jian-Yong ZOU ; Fo-Tian ZHONG ; Hong-He LUO
Journal of Southern Medical University 2009;29(11):2255-2258
OBJECTIVETo observe Notch1 expression in esophageal squamous cell carcinoma (ESCC) and investigate its relation with microvascular angiogenesis in the tumor.
METHODSTissue slices of 40 cases ESCC (cancer group) and 8 cases normal esophagus tissues (normal group) were obtained to analyze the expression of Notch1 and vascular endothelial growth factor (VEGF) using immunohistochemistry and estimate the microvessel density (MVD) in the tumor.
RESULTSNotch1 expression was significantly lower in the cancer group than in the normal group (P<0.05). In the cancer group, Notch1 expression was higher in highly differentiated than in poorly differentiated tumors (P<0.05) regardless of tumor infiltration or lymph nodes metastasis (P>0.05). VEGF expression and MVD were significantly higher in cancer group than in normal group, and showed significant differences between tumors with different differentiation degrees, infiltration and lymph node metastasis (P<0.05). Correlation analysis showed that Notch1 expression was inversely correlated to VEGF expression.
CONCLUSIONNotch1 may be an anti-oncogene in ESCC and affects cell differentiation in early stage of the malignancy. Abnormally low expression of Notch1 in ESCC may be one of the upstream factors to induce high expression of VEGF and increased MVD. The Notch1 pathway might play a key role in microvascular angiogenesis in ESCC.
Adult ; Aged ; Angiogenesis Inducing Agents ; metabolism ; Capillaries ; growth & development ; Carcinoma, Squamous Cell ; blood supply ; metabolism ; Esophageal Neoplasms ; blood supply ; metabolism ; Female ; Humans ; Male ; Middle Aged ; Neovascularization, Pathologic ; Receptor, Notch1 ; metabolism ; Vascular Endothelial Growth Factor A ; metabolism
5.Correlation between expression of matrix metalloproteinase-2 and angiogenesis in esophageal carcinoma.
Jie-ru LI ; Feng-ying QI ; Li LI
Chinese Journal of Oncology 2005;27(2):96-98
OBJECTIVETo study expression of MMP-2 in relation to microvessel density (MVD) in esophageal carcinoma.
METHODSForty-eight specimens of esophageal carcinoma (Ec) and 17 specimens of grade II + III epithelial dysplasia (Dy) close to the tumor and 12 specimens of normal tissue (Nt) along the incisional margin were examined by S-P immunohistochemical staining with anti-MMP-2 monoclonal antibody. An anti-CD34 monoclonal antibody was used to show MVD.
RESULTSMMP-2 expression in Ec was remarkably higher than that in Dy, which was higher than that in Nt. MMP-2 expression in Ec and Dy was significantly correlated with MVD in the tumor and nearby tissue. MMP-2 expression and MVD in Ec significantly associated with lymph node metastasis.
CONCLUSIONExpression of MMP-2 plays an important role in angiogenesis and lymph node metastasis of esophageal cancer.
Carcinoma, Squamous Cell ; blood supply ; enzymology ; secondary ; Esophageal Neoplasms ; blood supply ; enzymology ; pathology ; Female ; Humans ; Lymphatic Metastasis ; Male ; Matrix Metalloproteinase 2 ; metabolism ; Microcirculation ; enzymology ; pathology ; Middle Aged ; Neovascularization, Pathologic ; enzymology ; pathology
6.Screening of specific binding peptide targeting blood vessel of human esophageal cancer in vivo in mice.
Min ZHI ; Kai-chun WU ; Zhi-ming HAO ; Chang-cun GUO ; Jia-yin YAO
Chinese Medical Journal 2011;124(4):581-585
BACKGROUNDCancer of the esophagus and gastroesophageal junction remains a virulent malignancy with poor prognosis. Rapid progresses were made in chemotherapeutic agents and the development of molecular markers allowed better identification of candidates for targeted therapy. This study aimed to identify the candidate peptides used for anti-angiogenic therapy of esophageal cancer by in vivo screening C7C peptide library for peptides binding specifically to blood vessels of human esophageal cancer.
METHODSThe phage displayed C7C peptide library was injected intravenously into mice bearing human esophageal tumor xenografts under renal capsule. After 5 rounds of screening, 13 clones were picked up individually and sequenced. During each round of screening, titers of phage recovery were calculated from tumor xenograft and control tissues. Homing of these 9 peptides to tumor vessel was detected by calculating phage titers in the tumor xenograft and control tissues (lung and spleen) after each phage was injected into mice model, and compared with the distribution of phage M13 and VIII-related antigen in tumor xenograft by immunohistochemical staining. Comparisons among groups of data were made using one-way analysis of variance (ANOVA), followed by the Bonferroni multiple comparisons test.
RESULTSThe number of phage recovered from tumor tissue of each round increased gradually in tumor group while decreased in control groups (P < 0.01 in tumor and spleen, P < 0.05 in lung). Immunohistochemical staining showed similar staining pattern with M13 antibody or VIII-related antigen antibody, suggesting that phages displaying the selected peptides could home to blood vessel of human esophageal cancer. According to their DNA, 9 corresponding peptide sequences were deduced. And the homing ability to blood vessel of phages displaying the selected peptides was confirmed by comparing with their recovery in tumor and control tissues. Two motifs, YSXNXW and PXNXXN, were also obtained by analyzing the homology of these peptide sequences. The staining distribution of phage with the sequence of PNPNNST was similar to that of the blood vessel marker factor VIII-related antigen staining. After sequencing, each phage with the selected peptide of PNPNNST with 1.0 × 10(11) pfu/ml was injected intravenously into mice. The homing ability to tumor vessel of these 9 kinds of peptides in the xenograft was higher than control tissues (lung and spleen).
CONCLUSIONNine peptides obtained from in vivo screening homed to the blood vessel of human esophageal cancer, and the two motifs of YSXNXW and PXNXXN are the possible biochemical recognition units binding to vascular endothelial cells of esophageal cancer.
Animals ; Antineoplastic Agents ; therapeutic use ; Endothelial Cells ; drug effects ; Esophageal Neoplasms ; blood supply ; drug therapy ; metabolism ; Humans ; Immunohistochemistry ; Mice ; Mice, Inbred BALB C ; Peptide Library ; Peptides ; therapeutic use
7.A Prospective Study Comparing the Efficacy of Early Administration of Terlipressin and Somatostatin for the Control of Acute Variceal Bleeding in Patients with Cirrhosis.
Yeon Seok SEO ; Soon Ho UM ; Jong Jin HYUN ; Youn Ho KIM ; Sanghoon PARK ; Bo Ra KEUM ; Yong Sik KIM ; Yoon Tae JEEN ; Hong Sik LEE ; Hoon Jai CHUN ; Sang Woo LEE ; Jai Hyun CHOI ; Chang Duck KIM ; Ho Sang RYU
The Korean Journal of Hepatology 2006;12(3):373-384
BACKGROUND/AIMS: Terlipressin and somatostatin decrease portal venous pressure and they are used for the treatment of variceal bleeding. However, only a few studies have compared the efficacy of these drugs in combination with other procedures for hemostasis. Therefore, we performed a prospective study to compare the efficacy of terlipressin and somatostatin for controlling acute variceal bleeding when used in combination with other procedures for hemostasis. METHODS: A total of 98 patients, who presented with variceal bleeding from September 2003 to May 2005, were randomly divided into the somatostatin group or terlipressin group. We compared the 5-day failure rate (defined as failure to control bleeding, rebleeding or death within 5 days of admission) and the 6-week mortality. The prognostic factors for 5-day failure and 6-week mortality were also evaluated. RESULTS: There were no differences in baseline characteristics between the two groups. The overall 5-day failure rate and the cumulative 6-week mortality were 16.3% and 15.8%, respectively. The five-day failure rate and the cumulative 6-week mortality were not significantly different between the somatostatin and terlipressin groups. Hepatocellular carcinoma, the baseline serum creatinine level and endoscopic treatment for hemostasis were the significant predictors of 5-day failure; the baseline serum creatinine level was the predictor of 6-week mortality. CONCLUSIONS: Both somatostatin and terlipressin were effective and showed comparable efficacy for the control of the acute variceal bleeding in the setting of a combined therapeutic approach. The baseline serum creatinine level may be a significant predictor for patient failure at 5 days and the 6-week mortality.
Acute Disease
;
Aged
;
Carcinoma, Hepatocellular/complications
;
Esophageal and Gastric Varices/complications/*drug therapy
;
Female
;
Gastrointestinal Hemorrhage/complications/*drug therapy
;
Hemorrhage/complications/drug therapy
;
Hemostasis, Endoscopic
;
Humans
;
Liver/*blood supply
;
Liver Cirrhosis/*complications
;
Liver Diseases/drug therapy
;
Liver Neoplasms/complications
;
Lysine Vasopressin/administration & dosage/*analogs & derivatives/therapeutic use
;
Male
;
Middle Aged
;
Multivariate Analysis
;
Somatostatin/administration & dosage/*therapeutic use
;
Varicose Veins/complications/drug therapy
;
Vasoconstrictor Agents/administration & dosage/*therapeutic use